Cargando…
The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study
Whether infections before transplantation impair the survival of patients with severe aplastic anemia (SAA) remains unclear. The aim of this retrospective cohort analysis was to compare survival between patients with SAA who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) wi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510614/ https://www.ncbi.nlm.nih.gov/pubmed/36172387 http://dx.doi.org/10.3389/fimmu.2022.1004787 |
_version_ | 1784797473631371264 |
---|---|
author | Zhang, Yuanfeng Chen, Xin Yang, Donglin Pang, Aiming Zhang, Rongli Ma, Qiaoling Zhai, Weihua He, Yi Wei, Jialin Jiang, Erlie Han, Mingzhe Feng, Sizhou |
author_facet | Zhang, Yuanfeng Chen, Xin Yang, Donglin Pang, Aiming Zhang, Rongli Ma, Qiaoling Zhai, Weihua He, Yi Wei, Jialin Jiang, Erlie Han, Mingzhe Feng, Sizhou |
author_sort | Zhang, Yuanfeng |
collection | PubMed |
description | Whether infections before transplantation impair the survival of patients with severe aplastic anemia (SAA) remains unclear. The aim of this retrospective cohort analysis was to compare survival between patients with SAA who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) with infection (n=66) and patients without infection (n=189) from one medical center. There were no differences in baseline characteristics, except that more patients in the infection group were diagnosed with VSAA (59.09% vs. 30.69%, P<0.001), and their grafts were more peripheral blood stem cells (89.39% vs. 76.72%, P=0.042). In addition, the percentage of patients with multidrug-resistant organism colonization or infection in the infection group was larger (16.7% vs. 0.5%, P<0.001). The median days of engraftment were similar between the two groups; however, the 28-day engraftment rates of neutrophils and platelets were lower in the infection group. No differences were observed in terms of grades II–IV acute graft-versus-host disease (aGVHD) (P=0.418), grades III–IV aGVHD (P=0.075), mild to severe chronic GVHD (cGVHD) (P=0.899), and moderate to severe cGVHD (P=0.342). Patients in the infection group had more bloodstream infections before engraftment (28.8% vs. 15.3%, P=0.016), and the primary cause of death was infection instead of aGVHD in contrast to patients without infection (16.7% vs. 4.2%, P=0.002). Finally, the estimated overall survival (OS), failure-free survival (FFS), and GVHD-free FFS at 5 years were 63% (95% CI, 51–78), 60% (95% CI, 47–74), and 55% (95% CI, 43–70) in patients with infection before transplantation versus 86% (95% CI, 81–92) (P<0.001), 82% (95% CI, 76–88) (P<0.001), and 75% (95% CI, 69–82) (P=0.003) in patients without infection before transplantation, respectively. Multivariate analysis identified haploidentical HSCT and pre-HSCT anti-infection response, defined as partial remission (PR) or stable disease (SD), as adverse factors of OS and FFS. In conclusion, our study demonstrated that SAA patients with infection defined as PR or SD but not complete remission before allo-HSCT showed inferior survival compared with patients without infection. Therefore, more attention should be paid to prophylaxis and complete control of infectious complications before transplantation among SAA patients. |
format | Online Article Text |
id | pubmed-9510614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95106142022-09-27 The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study Zhang, Yuanfeng Chen, Xin Yang, Donglin Pang, Aiming Zhang, Rongli Ma, Qiaoling Zhai, Weihua He, Yi Wei, Jialin Jiang, Erlie Han, Mingzhe Feng, Sizhou Front Immunol Immunology Whether infections before transplantation impair the survival of patients with severe aplastic anemia (SAA) remains unclear. The aim of this retrospective cohort analysis was to compare survival between patients with SAA who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) with infection (n=66) and patients without infection (n=189) from one medical center. There were no differences in baseline characteristics, except that more patients in the infection group were diagnosed with VSAA (59.09% vs. 30.69%, P<0.001), and their grafts were more peripheral blood stem cells (89.39% vs. 76.72%, P=0.042). In addition, the percentage of patients with multidrug-resistant organism colonization or infection in the infection group was larger (16.7% vs. 0.5%, P<0.001). The median days of engraftment were similar between the two groups; however, the 28-day engraftment rates of neutrophils and platelets were lower in the infection group. No differences were observed in terms of grades II–IV acute graft-versus-host disease (aGVHD) (P=0.418), grades III–IV aGVHD (P=0.075), mild to severe chronic GVHD (cGVHD) (P=0.899), and moderate to severe cGVHD (P=0.342). Patients in the infection group had more bloodstream infections before engraftment (28.8% vs. 15.3%, P=0.016), and the primary cause of death was infection instead of aGVHD in contrast to patients without infection (16.7% vs. 4.2%, P=0.002). Finally, the estimated overall survival (OS), failure-free survival (FFS), and GVHD-free FFS at 5 years were 63% (95% CI, 51–78), 60% (95% CI, 47–74), and 55% (95% CI, 43–70) in patients with infection before transplantation versus 86% (95% CI, 81–92) (P<0.001), 82% (95% CI, 76–88) (P<0.001), and 75% (95% CI, 69–82) (P=0.003) in patients without infection before transplantation, respectively. Multivariate analysis identified haploidentical HSCT and pre-HSCT anti-infection response, defined as partial remission (PR) or stable disease (SD), as adverse factors of OS and FFS. In conclusion, our study demonstrated that SAA patients with infection defined as PR or SD but not complete remission before allo-HSCT showed inferior survival compared with patients without infection. Therefore, more attention should be paid to prophylaxis and complete control of infectious complications before transplantation among SAA patients. Frontiers Media S.A. 2022-09-12 /pmc/articles/PMC9510614/ /pubmed/36172387 http://dx.doi.org/10.3389/fimmu.2022.1004787 Text en Copyright © 2022 Zhang, Chen, Yang, Pang, Zhang, Ma, Zhai, He, Wei, Jiang, Han and Feng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhang, Yuanfeng Chen, Xin Yang, Donglin Pang, Aiming Zhang, Rongli Ma, Qiaoling Zhai, Weihua He, Yi Wei, Jialin Jiang, Erlie Han, Mingzhe Feng, Sizhou The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study |
title | The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study |
title_full | The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study |
title_fullStr | The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study |
title_full_unstemmed | The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study |
title_short | The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study |
title_sort | prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: a single-center, retrospective study |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510614/ https://www.ncbi.nlm.nih.gov/pubmed/36172387 http://dx.doi.org/10.3389/fimmu.2022.1004787 |
work_keys_str_mv | AT zhangyuanfeng theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT chenxin theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT yangdonglin theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT pangaiming theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT zhangrongli theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT maqiaoling theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT zhaiweihua theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT heyi theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT weijialin theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT jiangerlie theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT hanmingzhe theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT fengsizhou theprognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT zhangyuanfeng prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT chenxin prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT yangdonglin prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT pangaiming prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT zhangrongli prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT maqiaoling prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT zhaiweihua prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT heyi prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT weijialin prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT jiangerlie prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT hanmingzhe prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy AT fengsizhou prognosticimpactofpreviouslyinfectiouscomplicationsonallogeneichematopoieticstemcelltransplantationforpatientswithsevereaplasticanemiaasinglecenterretrospectivestudy |